Connect with us


How CBD Can Ride to the Rescue in the Opioid Crisis



In the United States over the past decade, as we can certainly all agree, we have faced a growing crisis in the form of an epidemic of addiction, abuse, and overdose centered around opioid painkillers, apart from and including illegal heroin use.

Now that the federal government has stepped up to the plate and named this a national crisis, we’ve begun to see scientists, politicians, and community leaders come together to join the battle.

But first, it’s critical to understand the nature of addiction.

Understanding Addiction

Addiction is so difficult to battle because it’s something of a ghost in the brain. One can never nail down exactly what it is that’s wrong until it’s too wrong to change without help. In fact, addiction is something like a hijacking wherein the functions and processes driving an individual’s behavior become dominated by something other than their true long-term self-interest.

We become irrational and work against ourselves strictly for the maintenance of the addiction. It is a fundamental rewiring of the brain.

Most addictions center around the release of the neurotransmitter dopamine. This is essentially the feel-good drug inside the brain. And other drugs that we take from the external world and put in our bodies can control how much of this internal drug is released and active and available for us to feel.

But dopamine is not just caused by drug intake. In fact, it rewards us for our evolutionary best interests. It’s like an internal design system meant to incentivize us toward the behaviors that are supposed to be helping us, such as eating, sleeping, and having sex.

Addictive substances play upon this internal instinctive equipment. They hijack the system that was meant to help us survive and reproduce and cause it to turn in on itself. They give us the reward without us having to work for it.

In other words, we were designed to be rewarded by an internal mechanism for behaviors that help our fitness and the fitness of our species. But when that reward is turned into a reward for another behavior altogether (such as taking the painkiller pill), it rewires our incentivization structure within the brain, causing a very different set of behaviors, many of which are highly self-destructive.

When this rewiring has taken place and become a self-reinforcing pattern of behavior in someone’s life, we have what we call an “addiction”.

The opioid crisis is essentially a segment of this societal problem that centers around prescriptions for opioid-based painkillers as well as heroin on the street. Opioids are in fact the most prescribed class of medicines in the United States.

And many people addicted to illegal opioids, such as heroine, began down this path following some sort of surgery where they faced an initial exposure to this type of drug. The need grew from there and soon only found release in illegal form. This illegal form also exposes them to dangers such as used needles and the potential for infections, including HIV.

CBD and the Opioid Crisis

Individuals who have been involved in an addiction involving opioids in the past, or those who have learned through other routes such as a family member’s addiction, are all too familiar with the deadly risks involved in exposure to something such as an opioid.

In these cases, many such individuals actually request that their doctor does not give them access to something that can become so deadly in its habit-forming properties. In such a case, individuals will choose to take nonsteroidal anti-inflammatory drugs such as Aleve, Voltaren, or ibuprofen.

However, many people don’t realize that one of the best natural alternatives here is actually CBD.

CBD creams, lotions, and oils have a number of different painkilling and anti-inflammatory properties, as we have covered exhaustively in many of our own pieces. In addition, other cannabinoids found in hemp and cannabis also have such properties.

CBD not only increases the strength of a signal that the sensory nerve requires but also functions to impact the immune system to prevent inflammation. And much pain and suffering that is targeted by opioids is actually rooted in inflammation on the cellular level.

In short, CBD is a valuable, effective, and healthy alternative option for those facing a potential move into an opioid-dominated life. Greater public awareness of this fact may serve to be a huge asset as we all work together to face down this terrible crisis.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories